Indivior Pharmaceuticals Inc
INDV
Classifica tra le azioni
#3878
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Prezzo delle azioni
$34.01
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$4.24B
Variazione (1 giorno)
4.81%
Variazione (1 anno)
40.02%
Paese
US
Scambia Indivior Pharmaceuticals Inc (INDV)
Categoria
Healthcare
Rapporto P/S per Indivior Pharmaceuticals Inc (INDV)
Rapporto P/S al October 2026 TTM: 3.20
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Indivior Pharmaceuticals Inc, il rapporto P/S attuale (TTM) è 3.20. Alla fine del 2023, era pari a 1.94.
Storico del rapporto P/S per Indivior Pharmaceuticals Inc da 2016 a 2026
Rapporto P/S alla fine di ogni anno
| Anno | Rapporto P/S | Cambia |
|---|---|---|
| 2026 (TTM) | 3.20 | 131.87% |
| 2024 | 1.38 | -28.93% |
| 2023 | 1.94 | -43.14% |
| 2022 | 3.42 | 5.76% |
| 2021 | 3.23 | 106.90% |
| 2020 | 1.56 | 235.34% |
| 2019 | 0.47 | -54.45% |
| 2018 | 1.02 | -70.40% |
| 2017 | 3.45 | 30.98% |
| 2016 | 2.64 | 0.00% |
Rapporto P/S per aziende simili o concorrenti
| Azienda | Rapporto P/S | Differenza del rapporto P/S | Il paese |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | 120.57% |
IN
|
